Denver Regenerative Medicine has introduced patient-education materials that clarify their definition of “rejuvenation therapy.” These documents outline the clinic’s protocols, the regulatory landscape, the scientific evidence, and the potential risks involved in these treatments.
Clarifying Terminology
The term “rejuvenation therapy” can often be misleading in the wellness industry, where it encompasses a wide range of treatments, from topical applications to injection techniques. At Denver Regenerative Medicine, however, it specifically refers to their REjuvenate protocol. This approach combines bio-identical hormone replacement therapy with autologous cell-based injections derived from the patient’s own fat and bone marrow.
Regulatory Framework
The educational materials distinctly categorize the two components of the protocol according to their regulatory status. Hormone therapy, overseen by Dr. Andrew Hong, the clinic’s medical director, utilizes FDA-approved products, which are only prescribed after comprehensive laboratory testing. Each hormone product comes with its own set of labeled risks and contraindications.
In contrast, the cell-based injections do not have the same level of FDA approval. Currently, no stem cell products have received FDA clearance for orthopedic or age-related applications. Certain procedures using minimally manipulated tissues can operate under an exemption from premarket review as outlined in Section 361 of the Public Health Service Act. However, it is important to note that this exemption does not equate to FDA approval.
Evidence and Risks
The materials emphasize that research on cell-based orthopedic procedures remains in its infancy. The American Academy of Orthopaedic Surgeons has criticized the available evidence as insufficient. Individual responses to these treatments can be unpredictable, and the clinic outlines several potential risks, including infection, bleeding, pain at the injection site, nerve irritation, and the possibility of no clinical benefit.
Additionally, the FDA has reported adverse events related to unapproved regenerative medicine products, which can include severe infections, blindness, and tumor formation. Patients should also be aware that these procedures are typically not covered by insurance, requiring them to pay out of pocket.
Environmental Considerations
One interesting aspect mentioned in the materials is the environmental context of Denver. The city’s elevation of approximately 5,280 feet reduces barometric pressure and, consequently, the partial pressure of inspired oxygen. The World Health Organization indicates that ultraviolet levels increase by about 10 percent for every 1,000 meters of elevation. However, the clinic does not claim that altitude accelerates cellular aging, nor does it position elevation as a criterion for treatment.
Commitment to Transparency
Dr. Andrew Hong emphasizes the importance of transparency regarding the treatments offered. He states, “Patients deserve to know which components of a protocol are FDA-approved drugs and which are procedures operating under an exemption, because those are not the same thing.” The clinic opts to publish the evidence limitations rather than allowing marketing language to obscure clinical realities.
Evaluation Process
The evaluation process for patients interested in the REjuvenate protocol begins with comprehensive blood panels that assess hormone levels, inflammatory markers, and metabolic function. This is followed by additional laboratory testing at 90-day intervals and reviews every six to twelve months. Typically, patients eligible for this protocol are adults aged between 35 and 65, with many able to return to their regular activities on the same day as their treatment.
Conclusion
Denver Regenerative Medicine’s focus on patient education highlights the importance of understanding the nuances of rejuvenation therapy. By clearly defining their protocols, regulatory status, and risks, they empower patients to make informed decisions regarding their health. As the field of regenerative medicine continues to evolve, such transparency will be crucial for patient trust and safety.
- Key Takeaways:
- Rejuvenation therapy at Denver Regenerative Medicine combines hormone therapy with cell-based injections.
- Regulatory pathways differ for hormone treatments and minimally manipulated cell therapies.
- Current research on cell-based procedures is still in early stages, with risks to consider.
- Patients should be prepared for out-of-pocket expenses as these treatments are generally not covered by insurance.
- Transparency in treatment protocols fosters informed patient decision-making.
Read more → www.desmoinesregister.com